Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.

AUTOR(ES)

Wu, Q Y

RESUMO

Thrombin is a serine protease that acts as a procoagulant by clotting fibrinogen and activating platelets and as an anticoagulant by activating protein C in a thrombomodulin-dependent reaction. Fibrinogen and thrombomodulin bind competitively to an anion-binding exosite on thrombin. We prepared recombinant normal human thrombin and mutant thrombins with single amino acid substitutions in order to localize and distinguish the fibrinogen- and thrombomodulin-binding sites. Normal and mutant thrombins had similar amidolytic activity. Thrombin K52E had approximately 2.5-fold increased protein C-activating activity but only approximately 17% of normal fibrinogen-clotting activity. Thrombin R70E had normal fibrinogen-clotting activity but only approximately 7% of normal protein C-activating activity. Thrombin R68E had markedly reduced activity in both assays. Decreased activation of protein C correlated with decreased binding affinity for thrombomodulin, and ability to activate platelets correlated directly with fibrinogen-clotting activity. These results demonstrate that thrombins with predominantly anticoagulant or procoagulant activity can be created by mutagenesis and that thrombomodulin- and fibrinogen-binding sites on thrombin may overlap but are not identical.

Documentos Relacionados

• Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.
• Single amino acid substitutions uncouple the DNA binding and strand scission activities of Fok I endonuclease.
• Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin.
• An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.
• Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.